Erika K Harding (Erika Harding)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Spinal Cord Injury

Top Venues

Canadian journal of pain = Revue canadienne de la douleur

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Brendan B McAllister, Sierra Stokes-Heck, Erika K Harding, Nynke J van den Hoogen, Tuan Trang
Targeting Pannexin-1 Channels: Addressing the 'Gap' in Chronic Pain. CNS drugs 38 (2) (2024)
Hance Clarke, Mariana Bueno, Erika K Harding, Tuan Trang, Jason J McDougall
The Future Is Bright: Highlighting Trainee Contributions to the Canadian Journal of Pain. Canadian journal of pain = Revue canadienne de la douleur 7 (2) (2024)
Brendan B McAllister, Sierra Stokes-Heck, Erika K Harding, Nynke J van den Hoogen, Tuan Trang
Targeting Pannexin-1 Channels: Addressing the 'Gap' in Chronic Pain. CNS drugs 38 (2) (2024)
Hance Clarke, Mariana Bueno, Erika K Harding, Tuan Trang, Jason J McDougall
The Future Is Bright: Highlighting Trainee Contributions to the Canadian Journal of Pain. Canadian journal of pain = Revue canadienne de la douleur 7 (2) (2024)
Brendan B McAllister, Sierra Stokes-Heck, Erika K Harding, Nynke J van den Hoogen, Tuan Trang
Targeting Pannexin-1 Channels: Addressing the 'Gap' in Chronic Pain. CNS drugs 38 (2) (2024)
Brendan B McAllister, Sierra Stokes-Heck, Erika K Harding, Nynke J van den Hoogen, Tuan Trang
Targeting Pannexin-1 Channels: Addressing the 'Gap' in Chronic Pain. CNS drugs (2024)
Brendan B McAllister, Sierra Stokes-Heck, Erika K Harding, Nynke J van den Hoogen, Tuan Trang
Targeting Pannexin-1 Channels: Addressing the 'Gap' in Chronic Pain. CNS drugs 38 (2) (2024)
Erika K Harding, Annemarie Dedek, Robert P Bonin, Michael W Salter, Terrance P Snutch, Michael E Hildebrand
The T-type calcium channel antagonist, Z944, reduces spinal excitability and pain hypersensitivity. British journal of pharmacology 178 (17) (2021)